LU85976A1 - Composition pour inhiber le developpement des tumeurs,a base d'un derive d'acide peroxydiphosphorique - Google Patents

Composition pour inhiber le developpement des tumeurs,a base d'un derive d'acide peroxydiphosphorique Download PDF

Info

Publication number
LU85976A1
LU85976A1 LU85976A LU85976A LU85976A1 LU 85976 A1 LU85976 A1 LU 85976A1 LU 85976 A LU85976 A LU 85976A LU 85976 A LU85976 A LU 85976A LU 85976 A1 LU85976 A1 LU 85976A1
Authority
LU
Luxembourg
Prior art keywords
composition according
acid
parts
derivative
peroxydiphosphoric
Prior art date
Application number
LU85976A
Other languages
English (en)
French (fr)
Inventor
Abdul Gaffar
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of LU85976A1 publication Critical patent/LU85976A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LU85976A 1984-06-27 1985-06-26 Composition pour inhiber le developpement des tumeurs,a base d'un derive d'acide peroxydiphosphorique LU85976A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US62506784A 1984-06-27 1984-06-27
US62506784 1984-06-27
US72654585A 1985-04-24 1985-04-24
US72654585 1985-04-24

Publications (1)

Publication Number Publication Date
LU85976A1 true LU85976A1 (fr) 1986-01-24

Family

ID=27089811

Family Applications (1)

Application Number Title Priority Date Filing Date
LU85976A LU85976A1 (fr) 1984-06-27 1985-06-26 Composition pour inhiber le developpement des tumeurs,a base d'un derive d'acide peroxydiphosphorique

Country Status (26)

Country Link
JP (1) JPH0623108B2 (pm)
KR (1) KR880002266B1 (pm)
AT (1) AT392002B (pm)
AU (1) AU578104B2 (pm)
BE (1) BE902732A (pm)
CH (1) CH668361A5 (pm)
DE (1) DE3523263A1 (pm)
DK (1) DK168191B1 (pm)
ES (1) ES8801122A1 (pm)
FI (1) FI84697C (pm)
FR (1) FR2566665B1 (pm)
GB (1) GB2161074B (pm)
GR (1) GR851575B (pm)
IE (1) IE58434B1 (pm)
IL (1) IL75518A0 (pm)
IT (1) IT1209961B (pm)
LU (1) LU85976A1 (pm)
MA (1) MA20467A1 (pm)
MC (1) MC1672A1 (pm)
NL (1) NL8501840A (pm)
NZ (1) NZ212301A (pm)
PH (1) PH25613A (pm)
PT (1) PT80707B (pm)
SE (1) SE468501B (pm)
WO (1) WO1986000225A1 (pm)
ZW (1) ZW9585A1 (pm)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3528379A1 (de) * 1985-08-07 1987-02-12 Peter Berger Mittel zur behandlung waessriger systeme sowie zur regenerierung von koerperzellen
DE3627759A1 (de) * 1985-08-22 1987-03-19 Colgate Palmolive Co Pharmazeutische zusammensetzung zum inaktivieren bakterieller endotoxine
FR2586350B1 (fr) * 1985-08-22 1992-05-15 Colgate Palmolive Co Composition pharmaceutique a base de peroxodiphosphate pour l'inhibition de la secretion d'hormone parathyroidienne
DE4201858A1 (de) * 1992-01-24 1993-07-29 Renschler Aloys Dr Med Mittel zur behandlung maligner zellen
KR100426450B1 (ko) * 2002-03-16 2004-04-13 박래옥 구연산, 알부민 및 아연을 함유한 항암 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4041149A (en) * 1976-01-12 1977-08-09 Colgate-Palmolive Company Composition and method of controlling and preventing mouth odor
US4430325A (en) * 1981-12-23 1984-02-07 Colgate-Palmolive Company Topical treatment of skin lesions

Also Published As

Publication number Publication date
IT1209961B (it) 1989-08-30
WO1986000225A1 (en) 1986-01-16
ES8801122A1 (es) 1988-01-01
IE58434B1 (en) 1993-09-22
FI84697B (fi) 1991-09-30
KR860000070A (ko) 1986-01-25
JPS6140217A (ja) 1986-02-26
JPH0623108B2 (ja) 1994-03-30
FI84697C (fi) 1992-01-10
SE8502876L (sv) 1985-12-28
GB8515105D0 (en) 1985-07-17
MA20467A1 (fr) 1985-12-31
SE8502876D0 (sv) 1985-06-11
SE468501B (sv) 1993-02-01
GR851575B (pm) 1985-11-25
KR880002266B1 (ko) 1988-10-21
NZ212301A (en) 1988-04-29
IL75518A0 (en) 1985-10-31
NL8501840A (nl) 1986-01-16
ATA188385A (de) 1990-07-15
BE902732A (fr) 1985-12-24
CH668361A5 (de) 1988-12-30
FR2566665B1 (fr) 1988-10-21
DK248085A (da) 1985-12-28
ES544565A0 (es) 1988-01-01
ZW9585A1 (en) 1985-11-13
FI852504A0 (fi) 1985-06-25
GB2161074A (en) 1986-01-08
AT392002B (de) 1991-01-10
DE3523263A1 (de) 1986-01-09
IT8548226A0 (it) 1985-06-17
PH25613A (en) 1991-08-08
IE851597L (en) 1985-12-27
DK168191B1 (da) 1994-02-28
FR2566665A1 (fr) 1986-01-03
AU578104B2 (en) 1988-10-13
DK248085D0 (da) 1985-06-03
MC1672A1 (fr) 1986-06-03
PT80707A (en) 1985-07-01
AU4418785A (en) 1986-01-02
PT80707B (en) 1986-12-09
GB2161074B (en) 1988-04-07
FI852504L (fi) 1985-12-28

Similar Documents

Publication Publication Date Title
JP4700808B2 (ja) フルボ酸、および種々の状態の処置におけるその使用
EP0385846A1 (fr) Composition pharmaceutique à libération prolongée d'acide valproîque
JP2004506657A (ja) 天然および合成ｈｃａのバイオアベイラブルな組成物
FR2759293A1 (fr) Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
LU82025A1 (fr) Preparation pharmaceutique comprenant un glycoside cardiaque en combinaison avec un polymere
JP2003002840A (ja) 脂肪性物質を基材とする脂溶性剤中にコートおよび／またはマイクロカプセル化されたＣｕｃｕｍｉｓｍｅｌｏ抽出物
JP3533737B2 (ja) 生体老化防止剤及び皮膚用組成物
LU85976A1 (fr) Composition pour inhiber le developpement des tumeurs,a base d'un derive d'acide peroxydiphosphorique
US4975423A (en) Inhibition of tumor development
JPS58206524A (ja) 抗腫瘍剤
EP4313155A1 (fr) Formulation par voie orale d'ivermectine et utilisations
JPH10504279A (ja) ウイルス感染症及び場合により炎症の予防及び／又は治療用医薬組成物並びにそれらの治療方法
JP2002510304A (ja) 移植体拒絶反応を防ぐためのビタミンｄ化合物の使用
EP0542979B1 (fr) Composition therapeutique pour liberation prolongee de magnesium
CA2669871A1 (fr) Composition terpenique anti-microorganisme
CH665637A5 (fr) 5-(3-n-butyloxalylaminophenyl)tetrazole comme agent antiasthmatique, composition le contenant et procede de preparation de la composition.
Ilango et al. Effect of Naga Parpam, a metallic drug of Siddha medicine, on lipid peroxidation, antioxidant enzymes and tissues of liver in Wistar rats
US12128019B1 (en) Nanocomposite including abscisic acid-loaded collagen nanoparticles
FR2586351A1 (fr) Composition pharmaceutique a base de peroxodiphosphate pour l'inactivation d'endotoxines bacteriennes
WO1996017616A1 (fr) Trousse pour cycle de traitement de l'osteoporose
RU2165757C1 (ru) Лечебно-профилактическое средство для молодняка сельскохозяйственных животных и птицы
EP0412877A1 (fr) Nouvelle forme galénique orale améliorant la biodisponibilité
EP0088016A1 (fr) Médicament à base de L-méthionine
FR2632523A1 (fr) Utilisation d'un extrait obtenu a partir d'une plante de la famille des resedacees, comme les resedas, pour la fabrication d'un medicament a activite antalgique ou analgesique et procede de fabrication d'un tel medicament
FR2659333A1 (fr) Nouveau derive organique d'un metal a structure phospholipide, utilisation de ce derive comme agent biomediateur, procede d'isolement de ce derive et compositions pharmaceutiques le contenant.

Legal Events

Date Code Title Description
DT Application date
TA Annual fee